Free tool
FAERS Monitor: Propecia
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 020788 or its brand name (Propecia, Finasteride). Reports on generic versions are filed under their own applications.
Reports
53,674
Serious
34,283
64% of reports
Hospitalization
13,544
Death reported
4,371
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- erectile dysfunction4,084
- fatigue3,692
- depression3,552
- anxiety2,953
- adverse drug reaction2,745
- sexual dysfunction2,364
- drug ineffective2,314
- dizziness2,149
- diarrhoea2,053
- death2,003
- insomnia1,973
- asthenia1,890
- dyspnoea1,858
- off label use1,827
- loss of libido1,689
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 249 |
| 2005 | 281 |
| 2006 | 295 |
| 2007 | 311 |
| 2008 | 350 |
| 2009 | 426 |
| 2010 | 639 |
| 2011 | 959 |
| 2012 | 1,492 |
| 2013 | 1,860 |
| 2014 | 1,882 |
| 2015 | 2,657 |
| 2016 | 2,905 |
| 2017 | 2,889 |
| 2018 | 3,540 |
| 2019 | 3,387 |
| 2020 | 3,835 |
| 2021 | 3,282 |
| 2022 | 3,038 |
| 2023 | 2,914 |
| 2024 | 4,912 |
| 2025 | 7,185 |
| 2026 | 4,385 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,000,485 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| sexual dysfunctionSignal | 2,364 | 98.7 | 94.4 | 182,563 |
| loss of libidoSignal | 1,689 | 90.4 | 85.8 | 121,226 |
| erectile dysfunctionSignal | 4,084 | 73.9 | 71.6 | 247,321 |
| adverse drug reactionSignal | 2,745 | 12.3 | 11.9 | 27,791 |
| depressionSignal | 3,552 | 6.2 | 6.0 | 15,406 |
| anxietySignal | 2,953 | 4.1 | 4.0 | 6,936 |
| insomniaSignal | 1,973 | 2.9 | 2.8 | 2,497 |
| asthenia | 1,890 | 2.0 | 1.9 | 920 |
| fatigue | 3,692 | 1.9 | 1.8 | 1,523 |
| dizziness | 2,149 | 1.7 | 1.6 | 619 |
| dyspnoea | 1,858 | 1.3 | 1.2 | 122 |
| diarrhoea | 2,053 | 1.2 | 1.2 | 103 |
| death | 2,003 | 0.9 | 0.9 | 18 |
| off label use | 1,827 | 0.8 | 0.8 | 78 |
| drug ineffective | 2,314 | 0.7 | 0.7 | 350 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.